Berberine Suppressed Tumor Growth through Regulating Fatty Acid Metabolism and Triggering Cell Apoptosis via

Lingli Li1, Ze Peng1, Qian Hu1,2

  • 1Institute of Integrated Traditional Chinese and Western Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430030, China.

Abstract

Insights

Berberine demonstrates anticancer effects against human gastric cancer by inducing apoptosis. This occurs through reduced fatty acid-binding protein (FABP) expression and increased fatty acid accumulation, impacting lipid metabolism.

Area of Science:

  • Oncology
  • Pharmacology
  • Biochemistry

Background:

  • Gastric cancer remains a significant global health challenge.
  • Berberine, a natural compound, has shown potential anticancer properties.
  • Understanding berberine's mechanism, particularly its role in lipid metabolism, is crucial for therapeutic development.

Purpose of the Study:

  • To investigate the antitumor mechanism of berberine in human gastric cancer.
  • To explore the role of lipid metabolism in berberine's anticancer effects.
  • To determine the impact of berberine on fatty acid-binding proteins (FABPs) and PPARα.

Main Methods:

  • In vitro assays: cell viability, proliferation, and apoptosis assays using MGC803 cells.
  • In vivo studies: ectopic xenograft models in Balb/c nude mice.
  • Biochemical analysis: assessment of fatty acid accumulation and FABP/PPARα protein expression.

Main Results:

  • Berberine inhibited MGC803 cell viability and proliferation in a dose- and time-dependent manner.
  • Berberine induced apoptosis in MGC803 cells and reduced tumor volume/weight in vivo.
  • Berberine led to fatty acid accumulation and suppressed FABP/PPARα expression, effects mimicked by a FABP inhibitor.

Conclusions:

  • Berberine exhibits significant anticancer effects against human gastric cancer both in vitro and in vivo.
  • The antitumor activity is mediated by berberine-induced apoptosis.
  • This apoptosis is linked to reduced FABP expression and consequent fatty acid accumulation, highlighting berberine's impact on lipid metabolism.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.5K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
8.0K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.8K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.5K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.5K